JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. (BKK:JSP)

BKK:JSP Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	29.49	20.65	100.2	623.9	0.49
Trading Asset Securities	-	-	209.81	27	-
Cash & Short-Term Investments	29.49	20.65	310.01	650.9	0.49
Cash Growth	42.78%	-93.34%	-52.37%	132077.56%	260.35%
Accounts Receivable	116.54	87.92	79.51	30.91	43.74
Other Receivables	40.02	34.71	27.89	32.14	7.33
Receivables	161.56	122.63	107.4	63.05	51.07
Inventory	122.42	102.15	99.37	109.48	77.89
Other Current Assets	0.19	0.18	1.25	0.72	0.54
Total Current Assets	313.66	245.61	518.02	824.15	129.99
Property, Plant & Equipment	905.47	865.36	670.23	396.54	214.95
Long-Term Investments	13.63	132.72	5.99	-	-
Goodwill	32.55	32.55	-	-	-
Other Intangible Assets	5.45	6.22	5.38	4.51	4.77
Long-Term Accounts Receivable	-	-	7.3	-	-
Long-Term Deferred Tax Assets	47.4	22.03	30.24	15.88	14.51
Long-Term Deferred Charges	0.24	0.73	0.68	0.21	-
Other Long-Term Assets	8.25	27.18	24.99	19.35	119.87
Total Assets	1,327	1,337	1,367	1,261	484.09
Accounts Payable	53.45	43.65	46.21	40.27	29.89
Accrued Expenses	3.92	1.81	1.66	-	-
Short-Term Debt	56.86	87.71	19.39	-	82.87
Current Portion of Long-Term Debt	28.07	10.53	10.06	12.87	22.41
Current Portion of Leases	17.88	10.36	8.06	2.86	6.95
Current Income Taxes Payable	17.06	-	2.74	-	3.09
Current Unearned Revenue	13.76	11.16	26.89	29.52	14.86
Other Current Liabilities	37.44	29.59	27	29.09	20.95
Total Current Liabilities	228.45	194.8	142	114.61	181.04
Long-Term Debt	50	56.27	37.62	69.63	61.46
Long-Term Leases	135.6	125.67	113.99	98.09	35.81
Long-Term Unearned Revenue	8.84	10.69	9.95	1.29	-
Long-Term Deferred Tax Liabilities	0.27	0.39	-	-	-
Other Long-Term Liabilities	1.2	1.16	-	-	0.05
Total Liabilities	444.13	405.57	316.94	294.21	288.17
Common Stock	237.29	237.28	227.5	227.5	170
Additional Paid-In Capital	772.53	772.49	733.46	733.46	22.09
Retained Earnings	-21.47	-9.81	-7.4	17	15.37
Comprehensive Income & Other	-130.35	-130.35	96.01	-11.54	-11.54
Total Common Equity	858	869.61	1,050	966.43	195.91
Minority Interest	24.52	62.22	0	-	-
Shareholders' Equity	882.52	931.83	1,050	966.43	195.91
Total Liabilities & Equity	1,327	1,337	1,367	1,261	484.09
Total Debt	288.41	290.53	189.12	183.45	209.51
Net Cash (Debt)	-258.92	-269.88	120.89	467.46	-209.02
Net Cash Growth	-	-	-74.14%	-	-
Net Cash Per Share	-0.55	-0.58	0.25	1.30	-0.62
Filing Date Shares Outstanding	474.58	474.56	455	455	340
Total Common Shares Outstanding	474.58	474.56	455	455	340
Working Capital	85.21	50.81	376.02	709.54	-51.05
Book Value Per Share	1.81	1.83	2.31	2.12	0.58
Tangible Book Value	819.99	830.84	1,044	961.91	191.15
Tangible Book Value Per Share	1.73	1.75	2.29	2.11	0.56
Land	227.84	227.84	187.52	165.09	59.82
Buildings	504.2	435.32	219.8	177.78	163.98
Machinery	339.6	268.71	190.54	119.75	105.78
Construction In Progress	-	42.78	159.17	7.66	2.65

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.